Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-17-003897
Filing Date
2017-05-11
Accepted
2017-05-11 14:38:55
Documents
1
Period of Report
2017-05-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7490313.html 3  
1 OWNERSHIP DOCUMENT p7490313.xml 3 6162
  Complete submission text file 0000919574-17-003897.txt   8726
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Issuer) CIK: 0001509190 (see all company filings)

EIN.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, SECOND FLOOR, 1344 GRAND CAYMAN E9 KY1-1108
Business Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, SECOND FLOOR, 1344 GRAND CAYMAN E9 KY1-1108 212-808-2460
Broadfin Healthcare Master Fund Ltd (Reporting) CIK: 0001511900 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35952 | Film No.: 17833785

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Reporting) CIK: 0001511901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35952 | Film No.: 17833784

Mailing Address C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
KOTLER KEVIN (Reporting) CIK: 0001601692 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35952 | Film No.: 17833783